Details for New Drug Application (NDA): 071569
✉ Email this page to a colleague
NDA 071569 describes DANAZOL, which is a drug marketed by Am Therap, Barr, and Lannett Co Inc, and is included in three NDAs. It is available from four suppliers. Additional details are available on the DANAZOL profile page.
The generic ingredient in DANAZOL is danazol. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the danazol profile page.
The generic ingredient in DANAZOL is danazol. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the danazol profile page.
Medical Subject Heading (MeSH) Categories for 071569
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
| Approval Date: | Dec 30, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
